Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
15:51:06 EDT Mon 14 Oct 2024
Enter Symbol
or Name
USA
CA



Z:RCUS - ARCUS BIOSCIENCES INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
RCUS - Z0.518.11·18.130.218.08-0.29-1.6235.84,0272,76018.255  18.70  17.92520.30  12.9615:32:51Oct 0915 min RT 2¢

Recent Trades - Last 10 of 2760
Time ETExPriceChangeVolume
15:32:51Z18.13-0.241
15:32:51Z18.13-0.241
15:32:50Z18.0717-0.29833
15:32:40Z18.0713-0.298710
15:32:26Z18.0708-0.299218
15:32:26Z18.115-0.25510
15:32:24Z18.0935-0.276511
15:32:21Z18.1037-0.266320
15:32:21Z18.0936-0.27641
15:32:21Z18.0896-0.28048

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-10-09 16:35U:RCUSNews ReleaseArcus Biosciences Announces New Employment Inducement Grants
2024-10-09 08:00U:RCUSNews ReleaseArcus Biosciences to Present First Clinical Data from ARC-20 Study at the 2024 EORTC-NCI-AACR Symposium
2024-10-02 16:05U:RCUSNews ReleaseArcus Biosciences Announces Clinical Trial Collaboration Agreement to Evaluate Casdatifan in Combination with Volrustomig in Renal Cell Carcinoma
2024-09-24 16:35U:RCUSNews ReleaseArcus Biosciences Announces New Employment Inducement Grants
2024-09-10 16:35U:RCUSNews ReleaseArcus Biosciences Announces New Employment Inducement Grants
2024-08-27 16:05U:RCUSNews ReleaseArcus Biosciences Secures Up to $250 Million Term Loan Facility from Hercules Capital
2024-08-26 16:35U:RCUSNews ReleaseArcus Biosciences Announces New Employment Inducement Grants
2024-08-21 16:05U:RCUSNews ReleaseArcus Biosciences to Participate in Two Upcoming Investor Conferences
2024-08-08 16:05U:RCUSNews ReleaseArcus Biosciences Reports Second-Quarter 2024 Financial Results and Provides a Pipeline Update
2024-08-01 08:00U:RCUSNews ReleaseSagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors
2024-07-25 16:05U:RCUSNews ReleaseArcus Biosciences to Host Conference Call to Discuss Second-Quarter 2024 Financial Results and Pipeline Update
2024-07-09 16:35U:RCUSNews ReleaseArcus Biosciences Announces New Employment Inducement Grants
2024-07-08 18:00U:RCUSNews ReleaseTaiho Pharmaceutical Exercises Option for an Exclusive License to Quemliclustat in Japan and Certain Territories in Asia
2024-06-25 16:35U:RCUSNews ReleaseArcus Biosciences Announces New Employment Inducement Grants
2024-06-11 16:35U:RCUSNews ReleaseArcus Biosciences Announces New Employment Inducement Grants
2024-06-10 08:30U:RCUSNews ReleaseArcus Biosciences Completes Patient Enrollment in Phase 3 Trial Evaluating a Domvanalimab-Containing Regimen in First-Line Metastatic Upper GI Cancers
2024-06-06 16:05U:RCUSNews ReleaseArcus Biosciences to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
2024-06-02 08:00U:RCUSNews ReleaseGilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer
2024-06-01 08:00U:RCUSNews ReleaseGilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers